KKR — KKR & Co. Inc.

The tape and the analyst community disagree. As of 2026-09-13, the stock had fallen 8.85% in one month and 6.17% in one week, is down ~33% from its 52-week high of $152.10, and carries a 1.79 beta — investors are de-risking a high-beta, rate-sensitive name. Meanwhile Q2 2026 (reported July 30, 2026) adjusted EPS of $1.63 beat the $1.36 consensus by ~20%, the firm completed a $2.1B leveraged loan financing at par with a tighter-than-expected spread for its $5.7B Integer Holdings acquisition, and 24 of 27 analysts rate it Buy with a $126.78 average target (24 buy / 3 hold / 0 sell). Constructive fundamentals, negative price action nets out to Neutral, not Bullish.

Revenue has grown from $3.27B in Q3 2023 to $5.66B in Q2 2026 (+73% over ~3 years), but the path is lumpy, not linear: YoY growth was +39% in Q1 2026, +78% in Q4 2025 and +13% in Q2 2026, while Q1 2025 was an outright loss (operating income -$706.7M, diluted EPS -$0.22) driven by mark-to-market/compensation rather than fee income. The more important trend is margin compression: operating margin fell from 30.6% in Q3 2023 to just 5.8% in Q2 2026, and TTM operating margin is 7.8% on a 22.5% gross margin even as revenue scaled. Reported earnings swing violently around a rising base (EPS $1.64 in Q3 2023, -$0.22 in Q1 2025, $0.70 in Q2 2026), and free cash flow is extremely volatile ($3.20B in Q2 2026 vs -$4.93B in Q4 2025) because investment and financing flows dominate. Read: revenue is in a structural uptrend and the last four quarters are recovering from a weak patch, but GAAP margins are compressing and earnings quality is noisy — this is volatility around growth, not a clean acceleration.

As of 2026-09-13 the stock trades at 30.08x TTM GAAP EPS ($3.519) versus a 5-year average TTM P/E of 30.58x — essentially in line with its own history, which is exactly why the deterministic overlay labels valuation 'Neutral vs. its own history.' On forward numbers it looks cheaper: the next-FY street EPS estimate of $6.626 implies a forward P/E of only ~15.3x at $101.08, and the reported PEG of 0.618 is low. P/S of 4.31x is below the 5-year average of 5.19x, while P/B of 2.92x and a 0.73% dividend yield round out a picture that is not stretched. The catch: the forward estimate is ~1.9x trailing GAAP EPS, so the 'cheap' forward multiple depends entirely on adjusted/carried-interest earnings showing up. Verdict: fair on trailing earnings, modestly cheap on forward — not a bargain, not expensive.

The entire debate is the bridge from $3.52 of trailing GAAP EPS to $6.63 of forward adjusted EPS. At $101.08 the market is willing to pay ~15x for earnings that have not been earned yet, while insisting on ~30x for the earnings that have. Practically: if fee-related earnings growth and carried-interest realization deliver the step-up (Q3 2026 consensus is $1.57), the stock is inexpensive and the $126.78 consensus target is reachable; if exit markets stall and carry does not convert, the market re-rates it back toward 20-25x the current GAAP number, which implies roughly $70-88. The tell each quarter is the adjusted-versus-GAAP spread and realized carry, not the headline beat — Q2 2026's $0.70 GAAP diluted EPS sits well below the $1.63 adjusted figure the beat was measured on.

As of 2026-09-13, RSI(14) stood at 40.5 — weak-leaning but not oversold — with the price 5.94% below the 20-day SMA, 2.39% below the 50-day (roughly $103.6) and 4.11% below the 200-day (roughly $105.4). Short-term momentum is clearly negative (1-week -6.17%, 1-month -8.85%), but 3-month (+5.03%) and 6-month (+17.63%) returns are still positive, so this reads as a sharp pullback inside a medium-term uptrend rather than a confirmed breakdown. Having lost all three moving averages, there is no reclaimed support yet; entry discipline argues for waiting for either an RSI washout below 30 or a reclaim of the 50-day (~$104) before adding.

• Rate path / 'higher-for-longer': KKR's credit and leveraged-lending platforms are directly rate-sensitive, and a higher discount rate pressures both carry and exit multiples; a dovish pivot would be a meaningful tailwind.
• Private credit and leveraged loan demand remains robust — KKR's $2.1B loan backing the Integer Holdings deal cleared at par with a tighter-than-expected spread (2.5 points over benchmark), evidence institutional appetite for PE-backed debt is intact.
• Exit/IPO market recovery: realized carried interest depends on M&A and IPO windows reopening, which drive the lumpy performance income and net income volatility.
• High-beta risk asset: a beta of 1.79 means KKR trades as a leveraged proxy for equity markets, so risk-off episodes hit the stock harder than the index.
• Carried-interest tax treatment and private-markets regulation remain structural overhangs for all alternative asset managers.

• Q3 2026 earnings on November 6, 2026 (consensus EPS $1.57) — fee-related earnings, realized carry and deployment pace toward the firm's 2030 AUM targets are the numbers to watch.
• Closing and financing of the $5.7B Integer Holdings acquisition, including the $2.1B leveraged loan priced in mid-September 2026.
• Infrastructure JV with Enbridge for the Westcoast Pipeline System and other announced deployments, plus the sale of a minority stake in Nordic Bioscience and the BookMyShow investment.
• Fundraising momentum — new fund vintages convert into management fees for years and are the backbone of the fee-related earnings story.
• A dovish shift in rates or a reopening of the IPO/M&A window, which would accelerate carry realization and likely re-rate the multiple.

• The GAAP-to-adjusted earnings gap: forward EPS of $6.626 is ~1.9x trailing GAAP EPS of $3.519, so the attractive 15x forward multiple evaporates if carry and mark-to-market gains do not materialize.
• Balance-sheet leverage and complexity: $49.5B of long-term debt against $31.0B of stockholders' equity (D/E 1.63) on a $414B asset base — a rate or credit shock hits both earnings and portfolio marks.
• Earnings volatility and margin compression: operating margin fell from 30.6% in Q3 2023 to 5.8% in Q2 2026, and Q1 2025 posted a -$0.22 GAAP loss.
• High beta (1.79) and a 52-week range of $82.67-$152.10 — the stock has already drawn down ~33% from its high and can do so again quickly in a risk-off market.
• Private-markets competition, fee compression and potential carried-interest tax changes that would lower the after-tax economics of the model.

KKR is a high-quality franchise with a genuine growth engine trading at roughly 15x forward adjusted earnings, ~20% below the sell-side consensus target, with a fresh ~20% Q2 beat and an active deal pipeline. But the trailing GAAP numbers are volatile, reported operating margins are compressing, the balance sheet is levered 1.6x, and the tape is broken (below all moving averages, down 8.85% in a month). This is a buy-the-dip candidate for a risk-tolerant, long-horizon investor rather than a clean entry — the forward earnings step-up has to be earned, and the technicals do not yet confirm a bottom.

Forward P/E method: ~19.6x applied to the next-FY street adjusted EPS estimate of $6.626 (an implied forward P/E of just ~15.3x at the 2026-09-13 price of $101.08), which is a haircut to KKR's 5-year average trailing P/E of 30.58x — justified by the ~1.9x gap between adjusted forward EPS and TTM GAAP EPS of $3.519 — and a premium to where the stock trades now, reflecting franchise quality and 6-month price momentum of +17.63%.